Deutsche Bank Ag\ Global Blood Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $1.83 Million - $3.84 Million	56,371 Added 26.93%	265,681 $18.1 Million
Q2 2022 Aug 11, 2022	BUY	$22.3 - $37.39 $600,003 - $1.01 Million	26,906 Added 14.75%	209,310 $6.69 Million
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $3.19 Million - $4.42 Million	-124,304 Reduced 40.53%	182,404 $6.32 Million
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $464,609 - $751,211	-18,659 Reduced 5.73%	306,708 $8.98 Million
Q3 2021 Nov 04, 2021	SELL	$25.48 - $37.34 $1.42 Million - $2.08 Million	-55,637 Reduced 14.6%	325,367 $8.29 Million
Q2 2021 Aug 11, 2021	BUY	$32.46 - $43.42 $1.94 Million - $2.6 Million	59,849 Added 18.64%	381,004 $13.3 Million
Q1 2021 May 13, 2021	BUY	$38.94 - $50.85 $2.33 Million - $3.05 Million	59,894 Added 22.92%	321,155 $13.1 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $3.43 Million - $5.81 Million	91,151 Added 53.58%	261,261 $11.3 Million
Q3 2020 Nov 12, 2020	BUY	$52.76 - $74.49 $3.38 Million - $4.77 Million	64,074 Added 60.43%	170,110 $9.38 Million
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $570,482 - $957,866	11,707 Added 12.41%	106,036 $6.69 Million
Q1 2020 May 14, 2020	SELL	$41.72 - $87.2 $182,525 - $381,500	-4,375 Reduced 4.43%	94,329 $4.82 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $3.27 Million - $5.85 Million	71,519 Added 263.08%	98,704 $7.85 Million
Q3 2019 Nov 14, 2019	SELL	$45.35 - $57.91 $1.68 Million - $2.14 Million	-37,008 Reduced 57.65%	27,185 $1.32 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $2.37 Million - $2.85 Million	44,962 Added 233.8%	64,193 $3.38 Million
Q1 2019 May 15, 2019	SELL	$39.99 - $53.48 $2.17 Million - $2.91 Million	-54,376 Reduced 73.87%	19,231 $1.02 Million
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $5.12 Million - $7.58 Million	-162,417 Reduced 68.81%	73,607 $3.02 Million
Q3 2018 Dec 21, 2021	BUY	$38.0 - $51.1 $5.16 Million - $6.94 Million	135,782 Added 135.45%	236,024 $8.97 Million
Q3 2018 Nov 14, 2018	SELL	$38.0 - $51.1 $1.37 Million - $1.84 Million	-36,018 Reduced 26.43%	100,242 $3.81 Million
Q2 2018 Apr 21, 2020	BUY	$38.7 - $50.15 $1.25 Million - $1.62 Million	32,382 Added 31.17%	136,260 $6.16 Million
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $22.1 Million - $28.6 Million	-571,280 Reduced 84.61%	103,878 $4.69 Million
Q1 2018 Oct 18, 2019	BUY	$39.6 - $65.9 $3.8 Million - $6.33 Million	96,015 Added 16.58%	675,158 $32.6 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $17.6 Million - $29.2 Million	443,417 Added 326.7%	579,143 $28 Million
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $10.2 Million - $15.6 Million	-342,103 Reduced 71.6%	135,726 $5.34 Million
Q3 2017 Nov 14, 2017	BUY	$25.1 - $31.05 $12 Million - $14.8 Million	477,829	477,829 $14.8 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account